🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

LYKALABS vs SOLARA: Stock Comparison

LYKALABS vs SOLARA ACTIVE PHA SCIUpdated 1 Jul 26, 4:08 PM ISTNSE & company filings

SOLARA ACTIVE PHA SCI is the larger company by market capitalisation. LYKALABS shows a lower P/E, while SOLARA ACTIVE PHA SCI shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

LYKALABS leads 1; SOLARA leads 10 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

LYKALABSSOLARA

Valuation lens

What price are you paying?

Market CapContext only
₹279 Cr
₹3,100 Cr
P/E RatioLYKALABS has the lower reading
0x ✓
85.61x
P/B RatioSOLARA has the lower reading
2.67x
2.2x ✓
EPSSOLARA has the higher reading
₹0.57
₹5.9 ✓
Book ValueContext only
₹25.12
₹260.21
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SOLARA is the larger company
₹3,100 Cr vs ₹279 Cr
P/E Ratio
LYKALABS has a lower P/E
0x vs 85.61x
P/B Ratio
SOLARA has a lower P/B
2.2x vs 2.67x
EPS
SOLARA has higher earnings per share
₹5.9 vs ₹0.57
Revenue Growth (TTM YoY)
SOLARA has faster revenue growth
41.9% vs 0%
Qtr Sales Growth
SOLARA has stronger quarterly sales growth
9.37% vs 0%
Qtr Profit Growth
SOLARA has stronger quarterly profit growth
74.49% vs 0%
ROE
SOLARA has a higher ROE
-0.58% vs -37.11%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLYKALABSSOLARA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricLYKALABSSOLARA
Live Price₹74.83₹638.05
Day Change1.19%-2.62%
Volume88,55673,105
52-Week High₹98.25₹774
52-Week Low₹44.1₹422
Distance from 52W High-23.84%-17.56%

Valuation

MetricLYKALABSSOLARA
Market Cap₹279 Cr₹3,100 Cr
P/E Ratio0x85.61x
P/B Ratio2.67x2.2x
EPS₹0.57₹5.9
Book Value₹25.12₹260.21
Dividend Yield0%0%

Growth

MetricLYKALABSSOLARA
Revenue Growth (TTM YoY)0%41.9%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%9.37%
Qtr Profit Growth0%74.49%

Profitability & Leverage

MetricLYKALABSSOLARA
ROE-37.11%-0.58%
ROCE-22.29%4.66%
Net Margin-7.81%-0.54%
Operating Margin-24.74%6.36%
Debt to Equity0.56x0.49x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricLYKALABSSOLARA
Promoter Holding58.45%41.93%
FII Holding0.15%▼ 0.02 pp10.71%▼ 0.81 pp
DII Holding0.66%3.89%▲ 0.15 pp
Public Holding40.73%▲ 0.01 pp43.46%▲ 0.65 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: LYKALABS and SOLARA ACTIVE PHA SCI.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.